FDA's NDA And BLA Approvals
Executive Summary
Original new drugs and biologics recently approved by FDA.
You may also be interested in...
Keeping Track: Imbruvica Snags First-Line CLL Claim; Gilead TAF Strategy Advances
The latest drug development news and highlights from our FDA Performance Tracker.
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.